Related Experiment Video

Updated: Aug 13, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

Mark W Landis1, Basil S Pawlyk, Tiansen Li

  • 1Molecular Oncology Research Institute and Department of Radiation Oncology, Tufts-New England Medical Center, 750 Washington Street #5609, Boston, Massachusetts 02111, USA.

Cancer Cell
|January 18, 2006
PubMed

Insights

Cyclin D1's kinase activity is not essential for mammary gland development but is crucial for ErbB-2 initiated breast cancer. This suggests targeting cyclin D1-CDK4/6 kinase activity could be a specific therapeutic strategy for breast cancer.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncology

Background:

  • Cyclin D1 is a key regulator of the cell cycle, activating cyclin-dependent kinases (CDKs) CDK4 and CDK6.
  • It also influences CDK2 activity and transcription factor function.
  • Understanding the specific role of cyclin D1's kinase activity is crucial for targeted cancer therapies.

Purpose of the Study:

  • To investigate the necessity of cyclin D1-associated kinase activity in tissue development and tumorigenesis.
  • To determine if cyclin D1-CDK4/6 kinase activity is dispensable for normal development.
  • To assess the role of cyclin D1-CDK4/6 kinase activity in ErbB-2 driven breast cancer.

Main Methods:

  • Generation of "knockin" mice expressing a mutant cyclin D1 deficient in CDK4/6 activation.
  • Comparative analysis of mammary gland development in wild-type and mutant mice.
  • Assessment of breast cancer initiation and progression in response to ErbB-2 overexpression in both genotypes.

Main Results:

  • Mammary gland development proceeded normally in mice with mutant cyclin D1, indicating kinase activity is dispensable for this process.
  • The knockin mice exhibited significant resistance to breast cancers initiated by ErbB-2.
  • A clear distinction in the requirement for cyclin D1-CDK4/6 kinase activity between normal development and tumorigenesis was observed.

Conclusions:

  • Cyclin D1-associated kinase activity is largely dispensable for the development of cyclin D1-dependent tissues like the mammary gland.
  • Cyclin D1-CDK4/6 kinase activity plays a critical, non-redundant role in ErbB-2 driven breast cancer.
  • Targeting cyclin D1-dependent kinase activity represents a promising and specific therapeutic strategy for breast cancer treatment.

More Related Videos

Evaluation of Mammary Gland Development and Function in Mouse Models08:51

Evaluation of Mammary Gland Development and Function in Mouse Models

Published on: July 21, 2011

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...